DRM02 (formerly VAL-002) is a novel topical kinase inhibitor targeting inflammatory skin diseases. DRM02 is a selective inhibitor of a novel kinase involved in signaling for differentiation and migration in key cell types. Our objective with DRM02 is to achieve strong efficacy in inflammatory skin diseases, comparable to topical calcineurin inhibitors, without the risk of systemic toxicity.
Comparative Effect of Topical DRM02 in Phorbol Ester-Induced Skin Inflammation
DRM02 is currently in preclinical development in preparation for clinical trials.
